All RISE Unpacked episodes

RISE Unpacked · Episode 04 · 18 min 59 sec

Why Enterprise AI Deals Stall in Pharma

From Executive Enthusiasm to Organizational Commitment.

Unpacked by RISE series artwork

The technology works. The demonstration impresses. The executive sponsor is enthusiastic.

So why does the deal stall?

In Episode 04 of RISE Unpacked, we explore why promising enterprise AI initiatives struggle to move from successful pilots to organizational commitment and adoption.

Using RISE's New Enterprise Buying Map, Path to Yes™, and Action Gap™ frameworks, we examine the six constituencies that influence enterprise decisions, the hidden barriers that quietly prevent progress, and the critical role of the Alignment Architect in building shared confidence to act.

In this episode, we explore:

  • Why executive enthusiasm isn't the same as enterprise commitment
  • How the six buying constituencies shape decisions
  • The hidden power of the "quiet no"
  • Why organizations need an Alignment Architect
  • How to move from technical proof to measurable business value

The central takeaway: Enterprise AI success isn't simply a technology challenge. It's an organizational alignment and execution challenge.

Explore more at therisegroup.ai.

RISE — AI Powered. Human Led.

Listen to episode 04AI-hosted conversation based on a RISE framework.

Explore the ideas behind the conversation in the companion RISE framework.

Keep listening

More from RISE Unpacked

Episode 03 · 22 min 10 secWhy Pharma AI Pilots Don't Scale: The Enterprise AI Adoption Map™Episode 02 · 20 min 35 secWhy a Promising Pharma Deal Stalls: The Path to Yes™Episode 01 · 22 min 14 secWhy Boardroom Strategy Fails: The Action Gap™
FREE AI
Maturity™
Assessment
FREE AI Maturity™ Assessment